TickerFactsScreenerDevelopers

Cytosorbents Corp (CTSO) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $139.4K2011: $34.7K2012: $19.9K2013: $38.7K2014: $153.2K2015: $403.6K2016: $140.7K2017: $990.7K2018: $672.0K2019: $698.2K2020: $708.4K2021: $3.64M2022: $6.09M2023: $538.1K2024: $284.0K2025: $164.0K$164.0K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$164.0K-42.3%
2024$284.0K-47.2%
2023$538.1K-91.2%
2022$6.09M+67.2%
2021$3.64M+414.0%
2020$708.4K+1.5%
2019$698.2K+3.9%
2018$672.0K-32.2%
2017$990.7K+604.0%
2016$140.7K-65.1%
2015$403.6K+163.5%
2014$153.2K+295.9%
2013$38.7K+94.9%
2012$19.9K-42.7%
2011$34.7K-75.1%
2010$139.4K—